PRESS RELEASES

11 March |  2022

Prilenia to Present at Upcoming Virtual Investor Conferences

Naarden, NL, 11 March 2022  Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel treatments to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced that Dr. Michael R. Hayden, MD, Ph.D. Chief Executive Officer, will present at the following virtual investors conferences:

  • Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022, at 2:40 p.m. ET. Registration Link: click here

  • Stifel 2022 CNS Days on Tuesday, March 29, 2022. The Fireside chat will start at 12:30 p.m. ET.·      

  • Cantor Fitzgerald Rare Disease Day on Wednesday, March 30, 2022. The panel discussion will start at 11 a.m. ET.

 
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.prilenia.com for the latest information.